Meridian Bioscience Inc.

NASDAQ: VIVO · Real-Time Price · USD
33.97
0.00 (0.00%)
At close: Jan 30, 2023, 10:00 PM

Meridian Bioscience Balance Sheet Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year FY 2022 FY 2021
Period Ending Sep 30, 2022 Sep 30, 2021
Cash & Equivalents
81.45M 49.77M
Short-Term Investments
n/a n/a
Long-Term Investments
n/a n/a
Other Long-Term Assets
2.08M 365K
Receivables
47.23M 53.57M
Inventory
67.81M 76.84M
Other Current Assets
14.1M 12.63M
Total Current Assets
210.6M 192.81M
Property-Plant & Equipment
50.71M 49M
Goodwill & Intangibles
190.43M 198.82M
Total Long-Term Assets
252.5M 256.92M
Total Assets
463.1M 449.72M
Account Payables
17.76M 11.7M
Deferred Revenue
667K 638K
Short-Term Debt
1.83M 1.99M
Other Current Liabilities
37.7M 32.83M
Total Current Liabilities
57.95M 47.16M
Long-Term Debt
29.13M 63.93M
Other Long-Term Liabilities
7.96M 10.33M
Total Long-Term Liabilities
37.09M 74.26M
Total Liabilities
95.04M 121.42M
Total Debt
30.96M 65.92M
Common Stock
n/a n/a
Retained Earnings
223.16M 180.7M
Comprehensive Income
-10.5M 198K
Shareholders Equity
368.06M 328.3M
Total Investments
n/a n/a